Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes

M.M. Smits; L. Tonneijck; M.H.A. Muskiet; T. Hoekstra; M.H.H. Kramer; I.C. van den Pieters-van den Bos; D.L. Cahen; M. Diamant; D.H. van Raalte

doi:https://doi.org/10.1136/bmjopen-2015-009579

Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes

M.M. Smits, L. Tonneijck, M.H.A. Muskiet, T. Hoekstra, M.H.H. Kramer, I.C. van den Pieters-van den Bos, D.L. Cahen, M. Diamant, D.H. van Raalte

Research output: Contribution to journal › Article › Academic › peer-review

28 Citations (Scopus)

Original language	English
Article number	e009579
Journal	BMJ Open
Volume	5
Issue number	11
DOIs	https://doi.org/10.1136/bmjopen-2015-009579
Publication status	Published - 2015

Access to Document

https://doi.org/10.1136/bmjopen-2015-009579

Cite this

Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Hoekstra, T., Kramer, M. H. H., van den Pieters-van den Bos, I. C., Cahen, D. L., Diamant, M., & van Raalte, D. H. (2015). Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes. BMJ Open, 5(11), Article e009579. https://doi.org/10.1136/bmjopen-2015-009579

@article{ecf36982233144f9b35fe0ea10085cf4,

title = "Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes",

author = "M.M. Smits and L. Tonneijck and M.H.A. Muskiet and T. Hoekstra and M.H.H. Kramer and {van den Pieters-van den Bos}, I.C. and D.L. Cahen and M. Diamant and {van Raalte}, D.H.",

year = "2015",

doi = "https://doi.org/10.1136/bmjopen-2015-009579",

language = "English",

volume = "5",

journal = "BMJ Open",

issn = "2044-6055",

publisher = "BMJ Publishing Group",

number = "11",

}

Smits, MM , Tonneijck, L , Muskiet, MHA , Hoekstra, T , Kramer, MHH, van den Pieters-van den Bos, IC, Cahen, DL, Diamant, M & van Raalte, DH 2015, 'Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes', BMJ Open, vol. 5, no. 11, e009579. https://doi.org/10.1136/bmjopen-2015-009579

Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes. / Smits, M.M.; Tonneijck, L.; Muskiet, M.H.A. et al.
In: BMJ Open, Vol. 5, No. 11, e009579, 2015.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes

AU - Smits, M.M.

AU - Tonneijck, L.

AU - Muskiet, M.H.A.

AU - Hoekstra, T.

AU - Kramer, M.H.H.

AU - van den Pieters-van den Bos, I.C.

AU - Cahen, D.L.

AU - Diamant, M.

AU - van Raalte, D.H.

PY - 2015

Y1 - 2015

U2 - https://doi.org/10.1136/bmjopen-2015-009579

DO - https://doi.org/10.1136/bmjopen-2015-009579

M3 - Article

C2 - 26586327

SN - 2044-6055

VL - 5

JO - BMJ Open

JF - BMJ Open

IS - 11

M1 - e009579

ER -

Smits MM , Tonneijck L , Muskiet MHA , Hoekstra T , Kramer MHH, van den Pieters-van den Bos IC et al. Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes. BMJ Open. 2015;5(11):e009579. doi: https://doi.org/10.1136/bmjopen-2015-009579